PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Neurosurgery, Clinical Neuroscience Research Center, Tulane University School of Medicine, New Orleans, LA 70112, USA.\', \'Department of Neurosurgery, Clinical Neuroscience Research Center, Tulane University School of Medicine, New Orleans, LA 70112, USA; Tulane Brain Institute, Tulane University, New Orleans, LA 70112, USA; Department of Neurology, Tulane University School of Medicine, New Orleans, LA 70112, USA.\', \'Department of Neurosurgery, Clinical Neuroscience Research Center, Tulane University School of Medicine, New Orleans, LA 70112, USA; Tulane Brain Institute, Tulane University, New Orleans, LA 70112, USA; Department of Neurology, Tulane University School of Medicine, New Orleans, LA 70112, USA; Department of Microbiology and Immunology, Tulane University School of Medicine, New Orleans, LA 70112, USA; Tulane University School of Public Health and Tropical Medicine, New Orleans, LA 70122, USA. Electronic address: gbix@tulane.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0024-3205(21)00868-710.1016/j.lfs.2021.119881
?:doi
?:hasPublicationType
?:journal
  • Life sciences
is ?:pmid of
?:pmid
?:pmid
  • 34389403
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.071
?:rankingScore_hIndex
  • 145
is ?:relation_isRelatedTo_publication of
?:title
  • In Vivo protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all